Clari Vest Asset Management LLC Akebia Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$6.67 - $13.58 $460,897 - $938,378	-69,100 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$4.1 - $10.24 $122,999 - $307,200	-30,000 Reduced 30.27%	69,100 $524,000
Q4 2019 Feb 12, 2020	SELL	$3.16 - $6.73 $2,212 - $4,711	-700 Reduced 0.7%	99,100 $626,000
Q3 2019 Nov 12, 2019	SELL	$3.55 - $5.4 $3,195 - $4,860	-900 Reduced 0.89%	99,800 $391,000
Q2 2019 Aug 16, 2019	BUY	$4.1 - $8.05 $229,599 - $450,800	56,000 Added 125.28%	100,700 $487,000
Q1 2019 May 13, 2019	BUY	$5.41 - $8.73 $241,827 - $390,231	44,700 New	44,700 $366,000

127

62.8M

50.6K

203K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $351M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.